The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary


Jan 3, 2013

I am on and truvada. why do I get truvada when I have M184 mutation? why cant they give me something else instead of emtriva since emtriva is compormised. or just plain viread and prezista. I am on prezista, norvir and truvada?. Thank you

Response from Dr. Young

Hello and thanks for posting.

You're correct that the M184V mutation confers resistance to emtricitabine (FTC, Emtriva) and lamivudine (3TC, Epivir).

What's distinctly different about this drug resistance mutation and how we clinically handle it is that the same resistance mutation actually confers enhanced sensitivity to certain medications, including tenofovir and AZT.

So, the regimen that you're taking with tenofovir/FTC (Truvada) is frequently used, especially with a boosted PI (Prezista) regimen, to enhance the potency of the tenofovir part. [BTW, one can't just take Prezista without Norvir, as Norvir boosting is required for Prezista].

Hope that helps, BY

Re:How long we can alive in second line treatment

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint